As Sanger sequencing confirmed the segregation of the FAR2 variant with symptoms in patient 2 (Supplemental Figure 2) and as loss of FAR2 function is not linked to neurological disorder or agammaglobulinemia (33), we excluded it from being causal for these patients. This evidence concerns the gene FAR2 and nervous system disorder.